Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1996
10/10/1996CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
10/10/1996CA2217346A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996CA2217305A1 Cyclodextrin compounds and methods of making and use thereof
10/10/1996CA2217297A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996CA2217164A1 Sugar-modified cytostatics
10/10/1996CA2217048A1 Cyclic peptide antifungal agents
10/10/1996CA2216859A1 Thrombin inhibitors
10/10/1996CA2216654A1 Inhibitors of farnesyl-protein transferase
10/10/1996CA2216599A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
10/10/1996CA2216281A1 A method for the treatment of macular degeneration
10/10/1996CA2214143A1 Combination compositions containing benazepril or benazeprilat and valsartan
10/10/1996CA2213620A1 Antibodies for the detection of hla-g
10/10/1996CA2192473A1 Composition for inducing a mucosal immune response
10/09/1996EP0736770A2 An immunoreactive conjugate, method for its preparation, antibodies to said conjugate and a pharmaceutical composition and diagnostic device containing them
10/09/1996EP0736601A2 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
10/09/1996EP0736600A2 Use of an "immunodeficiency-virus suppressing lymphokine (ISL)" to inhibit the replication of viruses, in particular of retroviruses
10/09/1996EP0736544A1 Oral care compositions
10/09/1996EP0736543A2 Method for the production of monoclonal antibodies to proliferation-associated antigens of the cell nucleus
10/09/1996EP0736542A1 Peptides that induce antibodies which inhibit HIV-type retroviruses and antibodies specific for these peptides
10/09/1996EP0736541A1 Cyclic hexapeptide antifungal agents
10/09/1996EP0736303A2 Interferon solution
10/09/1996EP0736300A2 Use in a composition of a pyrimidine derivative substituted in position 6 as an activator and/or stabilizer of cyclooxygenase
10/09/1996EP0736299A1 Process for preparing a liposomal, water-dispersable, solid, dry, therapeutic formulation for oral administration
10/09/1996EP0736095A1 Human circulating cytokine cc-1
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736041A1 Transparent liquid for encapsulated drug delivery
10/09/1996EP0736039A1 Compounds with growth hormone releasing properties
10/09/1996EP0736038A1 Compounds with growth hormone releasing properties
10/09/1996EP0736036A1 Kininogen inhibitors
10/09/1996EP0736034A1 Dna encoding the wnt-x growth factor
10/09/1996EP0736002A1 Compound capable of introducing at least one molecule into a cell
10/09/1996EP0735896A1 Parathyroid hormone formulation
10/09/1996EP0735895A1 A method for preventing or controlling cataract
10/09/1996EP0735894A1 Composition and methods to improve neural outcome
10/09/1996EP0735893A1 Alteration of immune response using pan dr-binding peptides
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735887A1 $i(IN UTERO) GENE THERAPY FOR FETUSES
10/09/1996EP0735819A1 New cryptophycins
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0678089B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
10/09/1996EP0678088B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
10/09/1996EP0648123B1 INHIBITORS OF PROTEIN TYROSINE-PHOSPHATASE $g(a) FOR TREATMENT OF TUMORS
10/09/1996EP0528928B1 Interleukin-4 binding protein-gamma
10/09/1996EP0528820B1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
10/09/1996CN1133064A GRB3-3 gene, variants and uses thereof
10/09/1996CN1133063A DNA Molecule encoding for cellular uptake of mycobacterium tuberculosis
10/09/1996CN1133050A Composition and methods using nitroxides to avoid oxygen toxicity
10/09/1996CN1133049A Melanona-inhibiting protein
10/09/1996CN1133048A Oligopeptides derived from C-reactive protein fragments
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1133012A Pharmaceutical formulations of nerve growth factor
10/09/1996CN1132756A Antiviral ethers of aspartate protease substrate isosteres
10/08/1996US5563255 Antisense oligonucleotide modulation of raf gene expression
10/08/1996US5563254 Polynucleotides encoding genetically engineered mutant hemoglobins
10/08/1996US5563246 Sodium ion binding proteins
10/08/1996US5563245 Anti-obesity proteins
10/08/1996US5563244 Anti-obesity proteins
10/08/1996US5563243 Anti-obesity proteins
10/08/1996US5563156 Anticoagulants, antiasthma agents
10/08/1996US5563124 Osteogenic product and process
10/08/1996US5563123 Chimeric proteins
10/08/1996US5563122 Stabilized parathyroid hormone composition
10/08/1996US5563121 Phosphinate methylene ammonium linkage
10/08/1996US5563120 Cytokine preparation for immunotherapy
10/08/1996US5563059 Use of human inhibin and human activin to increase the number of mature primate oocytes
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996US5563047 Treating with transglutaminase, inactivating the transglutaminase at a desired degree of polymerization
10/08/1996US5563045 Porcine factor viii nucleotide sequences
10/08/1996US5563044 Process for the enzymatic preparation of GRF(1-44)NH2
10/08/1996US5563039 Tumor necrosis factor
10/08/1996US5562921 Stable solid pharmaceutical compositions containing enalapril maleate
10/08/1996US5562907 Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
10/08/1996US5562905 Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
10/08/1996US5562904 Retroviral transduction of cells using soluble complement inhibitors
10/08/1996US5562903 Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2
10/08/1996US5562902 Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
10/08/1996US5562899 Medical prevention of lacerations to the vagina and perineum
10/08/1996CA1338632C Cloning and sequencing of the gene which codes for a new pilinic subunit of bordetella pertussis
10/07/1996CA2170073A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
10/07/1996CA2146481A1 Method for immunization of mammals against atherosclerosis and pharmaceutical compositions for obtaining said immunization
10/03/1996WO1996030762A1 Insulin mimetic and enhancer assay
10/03/1996WO1996030539A1 Engineered acarid allergen and process for producing the same
10/03/1996WO1996030536A1 Egf-targeted nucleic acid delivery
10/03/1996WO1996030535A1 Gene transfer into the kidney
10/03/1996WO1996030532A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
10/03/1996WO1996030531A1 Gene expression in mammalian cells
10/03/1996WO1996030524A1 Human dna ligase iii
10/03/1996WO1996030523A2 Antigen presentation system based on retrovirus-like particles
10/03/1996WO1996030522A1 Dna molecule relating to suppression of gene expression and novel protein
10/03/1996WO1996030521A2 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid
10/03/1996WO1996030519A1 Haemophilus adhesion proteins
10/03/1996WO1996030516A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/03/1996WO1996030513A1 Apoptosis regulating gene
10/03/1996WO1996030512A1 Conditional expression system
10/03/1996WO1996030511A1 Polymorphic and multicopy members of mhc gene families
10/03/1996WO1996030506A1 Antibody to human betacellulin and use thereof
10/03/1996WO1996030408A1 Antibody to the syncytiotrophoblast antigen r80k and use thereof
10/03/1996WO1996030407A1 Bifunctional thrombin inhibitors bearing highly truncated fibrinogen recognition exosite binding component
1 ... 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 ... 3163